Skip to main content
. 2017 Apr 12;7:46452. doi: 10.1038/srep46452

Table 2. Results of μCT analysis of bone regeneration at medullar bone level for L-PRF-treated and control groups, in function of healing time.

Healing time Treatment TV (mm3) BV (mm3) BV/TV (%) TS(mm2) BS (mm2) BS/BV (mm−1) BS/TV (mm−1) Tb.Th (mm) Tb.Sp (mm) Tb.N (mm−1) i.S Tb.Pf(mm−1) SMI DA FD
28 days Control 46.22 (±11.07) A 3.67 (±1.79) B 9.02 (±6.90) B 79.35 (±14.66) A 51.38 (±30.11) B 13.78 (±3.32) B 1.27 (±1.12) B 0.36 (±0.08) A 2.02 (±0.59) A 0.26 (±0.22) B 13.57 (±5.68) B 2.78 (±2.67) B 2.17 (±0.89) B 2.79 (±1.79) A 2.65 (±0.05) A
L-PRF 47.48 (±10.91) A 2.56 (±1.18) B 5.52 (±2.50) B 81.18 (±14.60) A 41.73 (±15.01) B 17.93 (±6.47) B 0.91 (±0.38) B 0.30 (±0.09) A 2.00 (±0.41) A 0.19 (±0.11) B 12.46 (±3.44) B 5.84 (±10.65) B 2.16 (±1.77) B 2.33 (±0.81) A 2.56 (±0.16) A
14 days Control 43.72 (±7.78) A 7.12 (±2.51) A 16.47 (±6.03) A 76.32 (±10.27) A 271.10 (±104.19) A 37.43 (±6.02) A 6.35 (±2.78) A 0.15 (±0.06) B 0.52 (±0.28) B 1.27 (±0.69) A 16.14 (±5.40) A 7.91 (±11.88) B 2.61 (±1.66) B 1.29 (±0.17) B 2.40 (±0.11) B
L-PRF 47.12 (±11.16) A 7.78 (±2.10) A 16.98 (±4.86) A 80.70 (±14.87) A 318.83 (±103.91) A 40.82 (±8.08) A 7.18 (±3.20) A 0.16 (±0.07) B 0.60 (±0.42) B 1.40 (±0.95) A 19.37 (±4.45) A 3.35 (±6.33) B 2.00 (±0.63) B 1.22 (±0.07) B 2.45 (±0.08) B
7 days Control 44.50 (±4.06) A 2.2 (±0.59) B 5.08 (±1.41) B 77.20 (±5.43) A 57.03 (±55.07) B 23.88 (±18.86) B 1.36 (±1.46) B 0.28 (±0.11) A 1.58 (±0.74) A 0.24 (±0.20) B 11.06 (±2.86) B 26.55 (±13.07) A 7.16 (±2.28) A 1.96 (±0.65) A 2.39 (±0.22) B
LPRF 46.75 (±4.17) A 2.93±(0.97) B 6.39 (±2.61) B 80.20 (±5.55) A 60.52 (±37.42) B 19.37 (±6.06) B 1.34 (±0.93) B 0.30 (±0.08) A 1.46 (±0.45) A 0.25 (±0.21) B 13.54 (±2.85) B 26.72 (±7.21) A 8.15 (±2.03) A 1.82 (±0.33) A 2.45 (±0.09) B

Different capital letters within the same column indicate statistical significant differences between the healing time groups, irrespective to the treatment applied.